A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate

Rheumatology (Oxford). 2020 Dec 1;59(12):e140-e141. doi: 10.1093/rheumatology/keaa360.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Calcinosis / drug therapy*
  • Calcinosis / etiology
  • Child
  • Dermatomyositis / complications
  • Female
  • Humans
  • Male
  • Piperidines / therapeutic use*
  • Pyrimidines / therapeutic use*

Substances

  • Piperidines
  • Pyrimidines
  • tofacitinib